Meeting
2024 ASCO Breakthrough
In-hospital outcome of central nervous system malignancy with COVID-19 infection: Analysis from National Inpatient Sample (NIS).
Authors
Thanathip Suenghataiphorn
Griffin Hospital, Derby, CT
Thanathip Suenghataiphorn , Phuuwadith Wattanachayakul , Thitiphan Srikulmontri , Sakditad Saowapa , Kochakorn Buasri , Narathorn Kulthamrongsri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies
Sub Track
Real World Evidence/Real World Data
Citation
J Clin Oncol 42, 2024 (suppl 23; abstr 29)
DOI
10.1200/JCO.2024.42.23_suppl.29
Abstract #
29
Poster Bd #
A6
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Mortality and economic cost in common primary cancer admitted with COVID-19: Analysis of NIS 2020.
First Author: Thanathip Suenghataiphorn
Poster
2024 ASCO Breakthrough
Racial impact of secondary metastasis in patients with lung cancer: Evidence of US hospitals in 2020.
First Author: Thanathip Suenghataiphorn
Poster
2024 ASCO Annual Meeting
Global, national, and regional burden of brain and central nervous system cancer in youth under 20 from 1990-2019: A benchmarking analysis.
First Author: Priyatha Vemparala
Poster
2023 ASCO Quality Care Symposium
Analysing the colorectal cancer screening patterns during the COVID-19 pandemic and their effects on patient outcomes.
First Author: Joshua Ling